LPL Financial LLC lessened its holdings in Semler Scientific Inc. (NASDAQ:SMLR - Free Report) by 15.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 93,112 shares of the company's stock after selling 17,521 shares during the quarter. LPL Financial LLC owned 0.97% of Semler Scientific worth $3,371,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently added to or reduced their stakes in SMLR. Geode Capital Management LLC raised its position in Semler Scientific by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 140,423 shares of the company's stock worth $7,584,000 after purchasing an additional 4,464 shares during the period. Wells Fargo & Company MN raised its position in Semler Scientific by 618.3% in the 4th quarter. Wells Fargo & Company MN now owns 103,465 shares of the company's stock worth $5,587,000 after purchasing an additional 89,060 shares during the period. Invesco Ltd. purchased a new position in Semler Scientific in the 4th quarter worth $5,964,000. Legal & General Group Plc raised its position in Semler Scientific by 65.4% in the 4th quarter. Legal & General Group Plc now owns 2,056 shares of the company's stock worth $111,000 after purchasing an additional 813 shares during the period. Finally, Raymond James Financial Inc. purchased a new position in Semler Scientific in the 4th quarter worth $1,939,000. Hedge funds and other institutional investors own 49.37% of the company's stock.
Wall Street Analysts Forecast Growth
SMLR has been the topic of a number of recent analyst reports. Maxim Group raised shares of Semler Scientific to a "strong-buy" rating and set a $95.00 price target on the stock in a report on Wednesday, July 9th. Wall Street Zen lowered shares of Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd. Benchmark initiated coverage on shares of Semler Scientific in a report on Tuesday, July 8th. They issued a "buy" rating and a $101.00 price target on the stock. Finally, Cantor Fitzgerald cut their price target on shares of Semler Scientific from $61.00 to $60.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. One investment analyst has rated the stock with a sell rating, three have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Semler Scientific has a consensus rating of "Moderate Buy" and a consensus target price of $81.75.
Read Our Latest Research Report on Semler Scientific
Semler Scientific Stock Down 3.7%
Shares of SMLR stock opened at $33.84 on Friday. Semler Scientific Inc. has a 12 month low of $21.77 and a 12 month high of $81.56. The stock has a market cap of $501.00 million, a P/E ratio of 13.93 and a beta of 1.34. The company has a current ratio of 0.60, a quick ratio of 0.58 and a debt-to-equity ratio of 0.25. The company has a 50 day simple moving average of $37.47 and a two-hundred day simple moving average of $38.53.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $5.04 earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $5.31. Semler Scientific had a net margin of 86.20% and a return on equity of 43.84%. The business had revenue of $8.22 million during the quarter, compared to analyst estimates of $8.10 million.
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access